blood

Becton Dickinson warns of blood culture product delays (NYSE:BDX)

angelp/iStock via Getty Images Becton, Dickinson (NYSE:BDX) unit BD Life Sciences has warned customers that shipments of some of its BD BACTEC blood culture media products may be delayed in the coming months due to production issues. BD said in a letter to users dated July 11 that it hasContinue Reading

J&J Carvykti beat standard drugs in blood cancer (NYSE:JNJ)

In: Finance

Hailshadow Johnson & Johnson (NYSE:JNJ) announced Tuesday that its FDA-approved cell therapy Carvykti, developed with Legend Biotech (LEGN), outperformed standard of care in a Phase 3 trial for patients with a type of blood cancer called multiple myeloma. Citing interim data from its CARTITUDE-4 trial, the pharma giant said patientsContinue Reading

Becton Dickinson warns of blood culture product delays (NYSE:BDX)

J&J Carvykti beat standard drugs in blood cancer (NYSE:JNJ)

Generative AI for agriculture: How Agmatix is improving agriculture with Amazon Bedrock | Amazon Web Services

Generate financial industry-specific insights using generative AI and in-context fine-tuning | Amazon Web Services